Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: SBD121, a Synbiotic Medical Food for RA Management [NA]

View source ↗

Summary

The clinical trial of SBD121, a synbiotic medical food for rheumatoid arthritis management, has completed. Sponsor: Solarea Bio, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SBD121

Snippet

Sponsor: Solarea Bio, Inc | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED